Related Experiment Video
Updated: May 6, 2026
11:39
The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
38.4K
Psoriasis in pregnancy: a review (I)
V Ruiz1, E Manubens1, L Puig1
1Servicio de Dermatología, Hospital de la Santa Creu i Sant Pau, Barcelona, España.
Actas Dermo-Sifiliograficas
|November 5, 2013
Summary
Psoriasis management during pregnancy is challenging due to limited drug safety data for fetal development. This review offers current insights into psoriasis course, comorbidities, and safe treatment options for pregnant women.
Area of Science:
- Dermatology
- Obstetrics
- Pharmacology
Background:
- Psoriasis frequently affects women of childbearing age.
- Pregnancy necessitates careful consideration of disease extent, comorbidities, and fetal risks in treatment.
- Ethical constraints limit clinical trials on pregnant women, leading to scarce evidence on drug effects on fetal development.
Purpose of the Study:
- To provide an updated review of psoriasis during pregnancy.
- To discuss conditions associated with psoriasis in gestation.
- To outline recommended therapeutic protocols for pregnant patients.
Main Methods:
- Literature review of scientific evidence on psoriasis in pregnancy.
- Analysis of current therapeutic guidelines and drug safety data.
- Synthesis of information on disease course and management.
Main Results:
- Psoriasis presents unique challenges during pregnancy requiring careful management.
- Limited data exists on the safety of many psoriasis treatments for fetal development.
- Associated conditions and specific therapeutic strategies are discussed.
Conclusions:
- Pregnant women with psoriasis require individualized treatment plans.
- Evidence-based recommendations are crucial for managing psoriasis safely during gestation.
- Further research is needed to expand knowledge on drug safety in pregnancy.
Related Concept Videos
01:27Acne Infection
99
Acne is a multifactorial skin condition primarily affecting adolescents and young adults, with a global prevalence estimated to exceed 75% in this demographic. The condition is characterized by the formation of comedones (blackheads and whiteheads), papules, pustules, nodules, and, in severe cases, cysts, particularly in areas rich in sebaceous glands such as the face, neck, chest, and back. The pathogenesis involves increased sebum production, follicular hyperkeratinization, colonization by...
99
01:23Skin Diseases and Disorders
5.4K
Skin is the first line of defense and encounters a variety of microbes. Some pathogenic strains are often the cause of a broad range of infections of the skin and other body systems. These conditions can affect people of all ages and may have different causes, including genetic factors, infections, autoimmune reactions, environmental factors, and lifestyle choices.
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
5.4K
01:25Inflammatory Bowel Disease III: Crohn's Disease
75
Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
75
01:26Inflammatory Bowel Disease I: Introduction
79
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...
79
01:29Inflammatory Bowel Disease IV: Pharmacological Management
1.1K
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
1.1K
01:30Inflammatory Bowel Disease II: Crohn's Disease
1.6K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.6K